Compare VYGR & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | ONEW |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.0M | 174.4M |
| IPO Year | 2015 | 2019 |
| Metric | VYGR | ONEW |
|---|---|---|
| Price | $3.74 | $8.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $21.00 | $16.75 |
| AVG Volume (30 Days) | ★ 862.4K | 140.7K |
| Earning Date | 03-09-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.77 |
| Revenue | $10,135,000.00 | ★ $1,872,334,000.00 |
| Revenue This Year | $54.19 | N/A |
| Revenue Next Year | $20.22 | $3.27 |
| P/E Ratio | ★ N/A | $3.02 |
| Revenue Growth | N/A | ★ 5.62 |
| 52 Week Low | $2.65 | $8.17 |
| 52 Week High | $5.55 | $18.15 |
| Indicator | VYGR | ONEW |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 28.79 |
| Support Level | $3.36 | N/A |
| Resistance Level | $3.74 | $12.51 |
| Average True Range (ATR) | 0.32 | 0.69 |
| MACD | -0.06 | -0.17 |
| Stochastic Oscillator | 4.87 | 9.91 |
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.